Published in Gene Therapy Weekly, May 26th, 1997
The origins of glaucoma, which affects three to four million people in the United States and blinds 12,000 of them each year, have long been a mystery, but new evidence that a gene and its encoded protein are involved raises hope that an understanding of the mechanisms of the disease is within reach, and also suggests new treatment possibilities.
Within the eye, sources of biological stress such as trauma or injury generate injurious forms of oxygen called "free radicals,"...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.